Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation (DIC)

被引:45
作者
Toh, CH [1 ]
Giles, AR
机构
[1] Royal Liverpool Univ Hosp, Roald Dahl Haemostasis & Thrombosis Ctr, Liverpool L7 8XP, Merseyside, England
[2] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2002年 / 24卷 / 06期
关键词
clot waveform analysis; DIC; diagnosis; coagulation test;
D O I
10.1046/j.1365-2257.2002.00457.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transmittance waveform charts the changes in light transmittance on standard coagulation assays, such as the prothrombin time (PT) and activated partial thromboplastin time (APTT). Analysis and characterization of these data on photo-optical coagulation analysers provides additional qualitative and quantitative information to that obtained using the clotting time alone. The most thoroughly evaluated clinical application is that of the biphasic APTT waveform with disseminated intravascular coagulation (DIC). The degree of waveform abnormality correlates directly with the severity of haemostatic dysfunction and allows for both the prediction and monitoring from non-overt to overt DIC. As its performance is simple and rapid, this provides the means for targeting therapeutic intervention to an earlier stage of DIC. The recent identification that the mechanism underlying the biphasic waveform is a complex that exists in vivo between C reactive protein with very low density lipoprotein, provides potentially important insights into the molecular pathogenesis of DIC. Thus, in addition to the immediate clinical utility in diagnostic practice, it has important applications as a research tool. Preliminary experience in the application of this technology to the diagnosis and management of the haemophilias and the lupus anticoagulant syndrome has also provided evidence of the power and utility of waveform analysis in essentially simple clotting assays.
引用
收藏
页码:321 / 327
页数:7
相关论文
共 15 条
[1]   Septic shock [J].
Astiz, ME ;
Rackow, EC .
LANCET, 1998, 351 (9114) :1501-1505
[2]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[3]  
BRAUN PJ, 1997, THROMB DIATH HAEMO, V3, P1079
[4]   Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis [J].
Downey, C ;
Kazmi, R ;
Toh, CH .
THROMBOSIS AND HAEMOSTASIS, 1998, 80 (01) :65-69
[5]   Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation [J].
Downey, C ;
Kazmi, R ;
Toh, CH .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (01) :68-73
[6]   Classification of factor deficiencies from coagulation assays using neural networks [J].
Givens, TB ;
Braun, PJ .
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 1997, 46 (03) :129-143
[7]   Predicting the presence of plasma heparin using neural networks to analyze coagulation screening assay optical profiles [J].
Givens, TB ;
Braun, P ;
Fischer, TJ .
COMPUTERS IN BIOLOGY AND MEDICINE, 1996, 26 (06) :463-476
[8]   D-DIMER PLASMA-CONCENTRATION IN VARIOUS CLINICAL CONDITIONS - IMPLICATION FOR THE USE OF THIS TEST IN THE DIAGNOSTIC-APPROACH OF VENOUS THROMBOEMBOLISM [J].
RAIMONDI, P ;
BONGARD, O ;
DEMOERLOOSE, P ;
REBER, G ;
WALDVOGEL, F ;
BOUNAMEAUX, H .
THROMBOSIS RESEARCH, 1993, 69 (01) :125-130
[9]  
Shima M, 2002, THROMB HAEMOSTASIS, V87, P436
[10]  
SPERO JA, 1980, THROMB HAEMOSTASIS, V43, P28